Search

Displaying results 6891 - 6900 of 9313 in total
  1. Drug

    Epelsiban

    go.drugbank.com/drugs/DB11934
    Investigational

    Epelsiban has been investigated for the treatment of Premature Ejaculation.

  2. Drug

    Visilizumab

    go.drugbank.com/drugs/DB12053
    Investigational

    Visilizumab has been investigated for the treatment of Ulcerative Colitis.

  3. Drug

    PG-701

    go.drugbank.com/drugs/DB12252
    Investigational

    Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.

  4. Drug

    Nitroaspirin

    go.drugbank.com/drugs/DB12445
    Investigational

    Nitroaspirin has been investigated for the treatment of Intermittent Claudication.

  5. Drug

    Mavrilimumab

    go.drugbank.com/drugs/DB12534
    Investigational

    Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.

  6. Drug

    AC-430

    go.drugbank.com/drugs/DB12535
    Investigational

    AC430 has been investigated for the treatment of Rheumatoid Arthritis.

  7. Drug

    Tocotrienol

    go.drugbank.com/drugs/DB12647
    Investigational

    Tocotrienol has been investigated for the treatment of Cholesterol Lowering.

    Mixtures: NHF Tocotrienol E Plus Vitamin D3 SoftgelCategories: Vitamin E
  8. Drug

    BL-1020

    go.drugbank.com/drugs/DB05687
    Investigational

    BL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine).

  9. Drug

    Nanrilkefusp alfa

    go.drugbank.com/drugs/DB17480
    Investigational

    Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).

  10. Drug

    BEA-17

    go.drugbank.com/drugs/DB18574
    Experimental

    BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST.[L48330] It is under investigation for the treatment of glioblastoma.